Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons

In amyotrophic lateral sclerosis (ALS) spinal motor neurons (SpMN) progressively degenerate while a subset of cranial motor neurons (CrMN) are spared until late stages of the disease. Using a rapid and efficient protocol to differentiate mouse embryonic stem cells (ESC) to SpMNs and CrMNs, we now re...

Full description

Bibliographic Details
Main Authors: Disi An, Ryosuke Fujiki, Dylan E Iannitelli, John W Smerdon, Shuvadeep Maity, Matthew F Rose, Alon Gelber, Elizabeth K Wanaselja, Ilona Yagudayeva, Joun Y Lee, Christine Vogel, Hynek Wichterle, Elizabeth C Engle, Esteban Orlando Mazzoni
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2019-06-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/44423
_version_ 1818024063209046016
author Disi An
Ryosuke Fujiki
Dylan E Iannitelli
John W Smerdon
Shuvadeep Maity
Matthew F Rose
Alon Gelber
Elizabeth K Wanaselja
Ilona Yagudayeva
Joun Y Lee
Christine Vogel
Hynek Wichterle
Elizabeth C Engle
Esteban Orlando Mazzoni
author_facet Disi An
Ryosuke Fujiki
Dylan E Iannitelli
John W Smerdon
Shuvadeep Maity
Matthew F Rose
Alon Gelber
Elizabeth K Wanaselja
Ilona Yagudayeva
Joun Y Lee
Christine Vogel
Hynek Wichterle
Elizabeth C Engle
Esteban Orlando Mazzoni
author_sort Disi An
collection DOAJ
description In amyotrophic lateral sclerosis (ALS) spinal motor neurons (SpMN) progressively degenerate while a subset of cranial motor neurons (CrMN) are spared until late stages of the disease. Using a rapid and efficient protocol to differentiate mouse embryonic stem cells (ESC) to SpMNs and CrMNs, we now report that ESC-derived CrMNs accumulate less human (h)SOD1 and insoluble p62 than SpMNs over time. ESC-derived CrMNs have higher proteasome activity to degrade misfolded proteins and are intrinsically more resistant to chemically-induced proteostatic stress than SpMNs. Chemical and genetic activation of the proteasome rescues SpMN sensitivity to proteostatic stress. In agreement, the hSOD1 G93A mouse model reveals that ALS-resistant CrMNs accumulate less insoluble hSOD1 and p62-containing inclusions than SpMNs. Primary-derived ALS-resistant CrMNs are also more resistant than SpMNs to proteostatic stress. Thus, an ESC-based platform has identified a superior capacity to maintain a healthy proteome as a possible mechanism to resist ALS-induced neurodegeneration.
first_indexed 2024-12-10T03:54:15Z
format Article
id doaj.art-0f4bd1185c1e462d992daccca11bd0d2
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-12-10T03:54:15Z
publishDate 2019-06-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-0f4bd1185c1e462d992daccca11bd0d22022-12-22T02:03:10ZengeLife Sciences Publications LtdeLife2050-084X2019-06-01810.7554/eLife.44423Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neuronsDisi An0Ryosuke Fujiki1Dylan E Iannitelli2https://orcid.org/0000-0002-7654-9433John W Smerdon3Shuvadeep Maity4https://orcid.org/0000-0002-6031-4744Matthew F Rose5https://orcid.org/0000-0002-1148-4130Alon Gelber6Elizabeth K Wanaselja7Ilona Yagudayeva8Joun Y Lee9Christine Vogel10https://orcid.org/0000-0002-2856-3118Hynek Wichterle11https://orcid.org/0000-0002-7817-0080Elizabeth C Engle12Esteban Orlando Mazzoni13https://orcid.org/0000-0001-8994-681XDepartment of Biology, New York University, New York, United StatesDepartment of Neurology, Boston Children’s Hospital, Boston, United States; FM Kirby Neurobiology Center, Boston Children’s Hospital, Boston, United States; Department of Neurology, Harvard Medical School, Boston, United States; Medical Genetics Training Program, Harvard Medical School, Boston, United StatesDepartment of Biology, New York University, New York, United StatesDepartment of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United StatesDepartment of Biology, New York University, New York, United States; Center for Genomics and Systems Biology, New York University, New York, United StatesDepartment of Neurology, Boston Children’s Hospital, Boston, United States; FM Kirby Neurobiology Center, Boston Children’s Hospital, Boston, United States; Medical Genetics Training Program, Harvard Medical School, Boston, United States; Department of Pathology, Brigham and Women’s Hospital, Boston, United States; Department of Pathology, Boston Children’s Hospital, Boston, United States; Department of Pathology, Harvard Medical School, Boston, United States; Broad Institute of MIT and Harvard, Cambridge, United StatesDepartment of Neurology, Boston Children’s Hospital, Boston, United States; FM Kirby Neurobiology Center, Boston Children’s Hospital, Boston, United States; Broad Institute of MIT and Harvard, Cambridge, United StatesDepartment of Biology, New York University, New York, United StatesDepartment of Biology, New York University, New York, United StatesDepartment of Neurology, Boston Children’s Hospital, Boston, United States; FM Kirby Neurobiology Center, Boston Children’s Hospital, Boston, United StatesDepartment of Biology, New York University, New York, United States; Center for Genomics and Systems Biology, New York University, New York, United StatesDepartment of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United StatesDepartment of Neurology, Boston Children’s Hospital, Boston, United States; FM Kirby Neurobiology Center, Boston Children’s Hospital, Boston, United States; Department of Neurology, Harvard Medical School, Boston, United States; Medical Genetics Training Program, Harvard Medical School, Boston, United States; Broad Institute of MIT and Harvard, Cambridge, United States; Howard Hughes Medical Institute, Chevy Chase, United States; Department of Ophthalmology, Boston Children’s Hospital, Boston, United States; Department of Ophthalmology, Harvard Medical School, Boston, United StatesDepartment of Biology, New York University, New York, United States; NYU Neuroscience Institute, NYU Langone Medical Center, New York, United StatesIn amyotrophic lateral sclerosis (ALS) spinal motor neurons (SpMN) progressively degenerate while a subset of cranial motor neurons (CrMN) are spared until late stages of the disease. Using a rapid and efficient protocol to differentiate mouse embryonic stem cells (ESC) to SpMNs and CrMNs, we now report that ESC-derived CrMNs accumulate less human (h)SOD1 and insoluble p62 than SpMNs over time. ESC-derived CrMNs have higher proteasome activity to degrade misfolded proteins and are intrinsically more resistant to chemically-induced proteostatic stress than SpMNs. Chemical and genetic activation of the proteasome rescues SpMN sensitivity to proteostatic stress. In agreement, the hSOD1 G93A mouse model reveals that ALS-resistant CrMNs accumulate less insoluble hSOD1 and p62-containing inclusions than SpMNs. Primary-derived ALS-resistant CrMNs are also more resistant than SpMNs to proteostatic stress. Thus, an ESC-based platform has identified a superior capacity to maintain a healthy proteome as a possible mechanism to resist ALS-induced neurodegeneration.https://elifesciences.org/articles/44423stem cell differentiationALSmotor neurons
spellingShingle Disi An
Ryosuke Fujiki
Dylan E Iannitelli
John W Smerdon
Shuvadeep Maity
Matthew F Rose
Alon Gelber
Elizabeth K Wanaselja
Ilona Yagudayeva
Joun Y Lee
Christine Vogel
Hynek Wichterle
Elizabeth C Engle
Esteban Orlando Mazzoni
Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons
eLife
stem cell differentiation
ALS
motor neurons
title Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons
title_full Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons
title_fullStr Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons
title_full_unstemmed Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons
title_short Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons
title_sort stem cell derived cranial and spinal motor neurons reveal proteostatic differences between als resistant and sensitive motor neurons
topic stem cell differentiation
ALS
motor neurons
url https://elifesciences.org/articles/44423
work_keys_str_mv AT disian stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT ryosukefujiki stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT dylaneiannitelli stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT johnwsmerdon stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT shuvadeepmaity stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT matthewfrose stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT alongelber stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT elizabethkwanaselja stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT ilonayagudayeva stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT jounylee stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT christinevogel stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT hynekwichterle stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT elizabethcengle stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons
AT estebanorlandomazzoni stemcellderivedcranialandspinalmotorneuronsrevealproteostaticdifferencesbetweenalsresistantandsensitivemotorneurons